Navigation Links
UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Date:9/1/2011

ANAHEIM, Calif., Sept. 1, 2011 /PRNewswire/ -- Please replace the release dated August 24, 2011 with the following updated version.  First graph, second and third sentences added and should read: The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial markets on Friday, September 9, 2011.  This presentation will also be available at http://ir.questcor.com/sec.cfm.  Second graph, second and third sentences updated and should read: Don M. Bailey, President and Chief Executive Officer, and members of the executive management team are scheduled to provide an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.

The full updated release reads:

Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September

Questcor Pharmaceuticals, Inc. (NASDAQ:  QCOR) announced today that members of its executive management team will present at the following investor conferences in early September.  The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial markets on Friday, September 9, 2011.  This presentation will also be available at http://ir.questcor.com/sec.cfm.

  • The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City.  Don M. Bailey, President and Chief Executive Officer, and members of the executive management team are scheduled to provide an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.
  • UBS Global Life Sciences Conference at the Grand Hyatt in New York City.  Mr. Bailey is scheduled to present on Monday, September 19, 2011 at 10:30 a.m. ET.  A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the use of Acthar to treat systemic lupus erythematosus, for which Acthar is approved as both a maintenance therapy and to treat exacerbations.  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.  For more information, please visit www.questcor.com.


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
2. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
3. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
4. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
5. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
6. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
7. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
8. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
9. Questcor Pharmaceuticals Selects BDO USA as its Auditor
10. Questcor Reports 2010 Financial Results
11. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden ... Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
(Date:2/23/2017)... Research and Markets has announced the addition ... report to their offering. ... The latest research Fibromyalgia Drugs Price Analysis and ... global Fibromyalgia market. The research answers the following questions: ... Fibromyalgia and their clinical attributes? How are they positioned in the ...
(Date:2/23/2017)... Regulus Therapeutics Inc . (Nasdaq: RGLS), ... innovative medicines targeting microRNAs, today announced it will release ... Thursday, March 2, 2017 after the market closes. ... on March 2, 2017 at 5:00 p.m. Eastern Time ... results and provide a general business update.  A live ...
Breaking Medicine Technology:
(Date:2/24/2017)... Lawn, NJ (PRWEB) , ... February 24, 2017 ... ... with robust marketing services, which specializes in thought leadership , media relations, ... marketing campaigns and services that will be powered through Act-On, an intuitive marketing ...
(Date:2/24/2017)... Charlevoix, MI (PRWEB) , ... February 24, 2017 ... ... venue in Charlevoix, once again hosted their Military Wedding Giveaway, with the ... be hosted by Castle Farms with services generously donated from local vendors: A ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Justice jointly issued a letter to withdraw previous guidance issued by ... gender identity. The guidance issued in May 2016 by the Obama Administration came ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to the La Gorce Country Club in Miami Beach to host its Swirl: ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is ... KLS is a longtime supporter of the event. , "We are pleased that ... said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record ...
Breaking Medicine News(10 mins):